Form 8-K - Current report:
SEC Accession No. 0001564590-19-027936
Filing Date
2019-08-01
Accepted
2019-08-01 16:01:57
Documents
14
Period of Report
2019-08-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K acor-8k_20190801.htm   iXBRL 8-K 32998
2 EX-99.1 acor-ex991_24.htm EX-99.1 457468
3 GRAPHIC gzkx10lzbqvx000001.jpg GRAPHIC 4764
  Complete submission text file 0001564590-19-027936.txt   643612

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA acor-20190801.xsd EX-101.SCH 6193
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE acor-20190801_lab.xml EX-101.LAB 19069
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acor-20190801_pre.xml EX-101.PRE 11717
7 EXTRACTED XBRL INSTANCE DOCUMENT acor-8k_20190801_htm.xml XML 3416
Mailing Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502
Business Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502 914-347-4300
ACORDA THERAPEUTICS INC (Filer) CIK: 0001008848 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31938 | Film No.: 19992565
SIC: 2836 Biological Products, (No Diagnostic Substances)